GlassScriptPhysician profile
Marc Michelson
NPI 1720081961
$8,972.22
in general payments reported to CMS, 2019-2025
21 companies · $1,620 in 2025
The $1,620 reported for 2025 was more than what 86% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,235 · 2020: $192 · 2021: $504 · 2022: $1,171 · 2023: $1,553 · 2024: $2,697 · 2025: $1,620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,490 · Travel and Lodging: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,489.89 |
| Travel and Lodging | $1,379.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $4,408.54 | 2019-2025 | Clareon, Argos, Centurion |
| Sun Pharmaceutical Industries INC. | $965.16 | 2019-2025 | Cequa |
| Abbvie INC. | $664.98 | 2022-2025 | |
| Kala Pharmaceuticals, INC. | $526.91 | 2019-2020 | |
| Oyster Point Pharma, INC. | $526.61 | 2022-2025 | Tyrvaya |
| Johnson & Johnson Surgical Vision, INC. | $434.18 | 2019-2024 | One Series Ultra, Tecnis Iol, Tecnis Simplicity |
| Biotissue Holdings INC. | $318.08 | 2022-2025 | |
| Allergan, INC. | $248.33 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $137.69 | 2019-2021 | |
| Ocular Therapeutix, INC. | $116.37 | 2022-2025 | Dextenza |
| Glaukos Corporation | $110.65 | 2021-2024 | Radius |
| Ivantis, INC | $105.26 | 2021 | |
| Bausch & Lomb Americas INC. | $97.38 | 2023-2024 | Miebo, Vyzulta, Ic-8 Apthera Iol |
| Dompe US, INC. | $74.85 | 2022-2025 | Oxervate |
| Carl Zeiss Meditec USA, INC. | $55.68 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $52.61 | 2024-2025 | Iyuzeh |
| New World Medical,INC. | $36.09 | 2022-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Novartis Pharmaceuticals Corporation | $30.35 | 2020-2023 | |
| Lensar, INC. | $22.81 | 2023 | Lensar Laser System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.43 | 2019 | |
| Eyevance Pharmaceuticals LLC | $18.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Michelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.